With the global population aging and lifestyles becoming more sedentary, the incidence of kidney diseases is on the rise. Chronic Kidney Disease (CKD) and End Stage Renal Disease (ESRD) require long-term management, often necessitating dialysis as a life-sustaining treatment. As a result, the demand for dialysis machines and consumables is expected to increase steadily.
The growing prevalence of kidney diseases is particularly pronounced in developing countries, where access to healthcare and preventive measures is limited. In these regions, the burden of kidney disease is expected to contribute significantly to the dialysis market growth. In addition, lifestyle factors such as unhealthy diets, lack of physical activity, and increasing rates of diabetes and hypertension further contribute to the rising prevalence of kidney diseases worldwide.
The increasing prevalence of kidney diseases, including CKD and ESRD, serves as a significant factor driving the market growth. Furthermore, the demand for dialysis machines and consumables is expected to escalate as the number of patients with kidney diseases continues to rise, particularly due to factors such as aging populations, lifestyle changes, and the increasing incidence of conditions such as diabetes and hypertension.
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-dialysis-machines-and-consumables-market
Data Bridge Market Research analyzes that the Global Dialysis Machines and Consumables Market is expected to reach USD 23.22 billion by 2031 from USD 16.41 billion in 2023, growing at a CAGR of 4.6% in the forecast period of 2024 to 2031.
Key Findings of the Study
Increasing Awareness about Kidney Diseases
With greater awareness, individuals are more likely to recognize the symptoms of kidney disease early on and seek medical attention, leading to an increase in the number of patients requiring dialysis services. In addition, healthcare providers are also more proactive in screening patients for kidney disease, further contributing to the demand for dialysis services and products.
Awareness of kidney diseases has been raised through various initiatives such as public health campaigns, educational programs, and advocacy efforts by healthcare organizations, patient groups, and government agencies. These efforts aim to educate the public about the risk factors, symptoms, and treatment options for kidney diseases, and the importance of early detection and prevention measures. Social media, community events, and partnerships with healthcare providers also play a key role in increasing awareness and promoting kidney health.
There is a growing need for innovative solutions that can improve patient outcomes and enhance the efficiency of dialysis treatments as the demand for dialysis services and products continues to rise. Manufacturers have an opportunity to develop new technologies and products that address the evolving needs of patients and healthcare providers in the dialysis market.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Year
|
2022 (Customizable to 2016–2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Pricing in USD
|
|
Segments Covered
|
Type (Hemodialysis and Peritoneal), Product Type (Hemodialysis and Peritoneal Dialysis), Disease Type (Chronic and Acute), End Use (Hospitals, Dialysis Centers, Home Care Settings, and Others), Distribution Channel (Direct Tenders, Retail Sales, and Others)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, U.K., Italy, France, Spain, Russia, Switzerland, Turkey, Belgium, Netherlands, Rest of Europe, Japan, China, South Korea, India, Singapore, Thailand, Indonesia, Malaysia, Philippines, Australia, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Egypt, Saudi Arabia, U.A.E., Israel, and Rest of Middle East and Africa
|
|
Market Players Covered
|
Fresenius SE & Co. KGaA (Germany), Baxter (U.S.), NIPRO (Japan), Evoqua Water Technologies LLC (U.S.), Medtronic (Ireland), B. Braun SE (Germany), Nikkiso Co., Ltd. (Japan), JMS Co. Ltd. (Japan), Jafron Biomedical Co., Ltd (China), Asahi Kasei Medical Co., Ltd. (Japan), Atlantic Biomedical (India), dialifegroup (Switzerland), and Advin Health Care (India), among others
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework
|
Segment Analysis
The global dialysis machines and consumables market is segmented into five notable segments based on type, product type, disease type, end use, and distribution channel.
- On the basis of type, the market is segmented into hemodialysis and peritoneal
In 2024, the hemodialysis segment is expected to dominate the Global Dialysis Machines and Consumables Market
In 2024, the hemodialysis segment is expected to dominate the market with a market share of 81.27% due to its status as a standard treatment for kidney failure for many years and its well-established position in medical practice.
- On the basis of product type, the market is segmented into hemodialysis and peritoneal dialysis
In 2024, the hemodialysis segment is expected to dominate the Global Dialysis Machines and Consumables Market
In 2024, the hemodialysis segment is expected to dominate the market with a market share of 86.19% due to its efficiency in removing waste products and excess fluid from the blood, which helps in maintaining electrolyte balance and controlling blood pressure.
- On the basis of disease type, the market is segmented into chronic and acute. In 2024, the chronic segment is expected to dominate the market with a market share of 69.05%
- On the basis of end use, the market is segmented into hospitals, dialysis centers, home care settings, and others. In 2024, the hospitals segment is expected to dominate the market with a market share of 41.33%
- On the basis of distribution channel, the market is segmented into direct tenders, retail sales, and others. In 2024, the direct tenders segment is expected to dominate the market with a market share of 47.96%
Major Players
Data Bridge Market Research analyzes recognizes the following companies as the major women’s health players in the market that include Fresenius SE & Co. KGaA (Germany), Baxter (U.S.), NIPRO (Japan), Evoqua Water Technologies LLC (U.S.), and Medtronic (Ireland).
Market Developments
- In August 2023, Fresenius SE & Co. KGaA announced the FDA's 510(k) clearance for Versi HD with GuideMe Software, a fully redesigned self-guided interface for the company's VersiHD chronic home hemodialysis (HHD) equipment. The goal of VersiHD with GuideMe Software is to change how nurses and patients see HHD. This helped the company to expand its product line with availability in the market
- In April 2023, Medtronic and DaVita Inc. jointly launched Mozarc Medical, an independent company dedicated to transforming kidney health and advancing patient-centered technology solutions. This joint venture benefited both Medtronic and DaVita Inc. by allowing them to combine their expertise and resources to focus specifically on kidney health, potentially leading to improved patient outcomes and market growth in the kidney health sector
- In January 2022, Evoqua Water Technologies LLC finalized the acquisition of the renal business formerly operated by Mar Cor Purification, a subsidiary of STERIS Plc. This acquisition will broaden Evoqua's service presence in North America, strengthening its position in the healthcare sector
- In December 2021, ExThera Medical and Asahi Kasei Medical Co., Ltd., a core operating company of the Asahi Kasei Group, signed an exclusive distribution agreement in Japan for ExThera's Seraph 100 Microbind Affinity Blood Filter (Seraph 100). Under the agreement, ExThera Medical and Asahi Kasei Medical Co., Ltd. collaborated to secure regulatory approval of Seraph 100 for commercialization in Japan. This agreement, as a significant step, helped the company in the expansion of the intensive care business field
Regional Analysis
Geographically, the countries covered in this market report are U.S., Canada, Mexico, Germany, U.K., Italy, France, Spain, Russia, Switzerland, Turkey, Belgium, Netherlands, rest of Europe, Japan, China, South Korea, India, Singapore, Thailand, Indonesia, Malaysia, Philippines, Australia, rest of Asia-Pacific, Brazil, Argentina, rest of South America, South Africa, Egypt, Saudi Arabia, U.A.E., Israel, and rest of Middle East and Africa.
As per Data Bridge Market Research analysis:
North America is expected to dominate the Global Dialysis Machines and Consumables Market
North America is expected to dominate the market due to factors such as favorable reimbursement policies for dialysis treatment, the presence of major players and strategic initiatives, and the presence of highly developed medical and healthcare infrastructure.
Asia-Pacific is estimated to be the fastest-growing region in the Global Dialysis Machines and Consumables Market
Asia-Pacific is estimated to be the fastest-growing region in the market due to rising research activities in the region and the increasing burden of diseases among the population.
For more detailed information about the global dialysis machines and consumables market report, click here – https://www.databridgemarketresearch.com/reports/global-dialysis-machines-and-consumables-market
